Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 222

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Probiotics for the prevention of pediatric antibiotic-associated diarrhea

Johnston, Bradley C, Goldenberg, Joshua Z, Vandvik, Per O, Sun, Xin, Guyatt, Gordon H · 2011 · Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: Antibiotics alter the microbial balance within the gastrointestinal tract. Probiotics may prevent antibiotic-associated diarrhea (AAD) via restoration of the gut microflora. Antibiotics are prescribed frequently in children and AAD is common in this population. OBJECTIVES: The primary objectives were to assess the efficacy and safety of probiotics (any specified strain or dose) used for the prevention of AAD in children. SEARCH METHODS: MEDLINE, EMBASE, CENTRAL, CINAHL, AMED, and the Web of Science (inception to May 2010) were searched along with specialized registers including the Cochrane IBD/FBD review group, CISCOM (Centralized Information Service for Complementary Medicine), NHS Evidence, the International Bibliographic Information on Dietary Supplements as well as trial registries. Letters were sent to authors of included trials, nutra/pharmaceutical companies, and experts in the field requesting additional information on ongoing or unpublished trials. Conference proceedings, dissertation abstracts, and reference lists from included and relevant articles were also searched. SELECTION CRITERIA: Randomized, parallel, controlled trials in children (0 to 18 years) receiving antibiotics, that compare probiotics to placebo, active alternative prophylaxis, or no treatment and measure the incidence of diarrhea secondary to antibiotic use were considered for inclusion. DATA COLLECTION AND ANALYSIS: Study selection, data extraction as well as methodological quality assessment using the risk of bias instrument was conducted independently and in duplicate by two authors. Dichotomous data (incidence of diarrhea, adverse events) were combined using a pooled relative risk and risk difference (adverse events), and continuous data (mean duration of diarrhea, mean daily stool frequency) as weighted mean differences, along with their corresponding 95% confidence intervals. For overall pooled results on the incidence of diarrhea, sensitivity analyses included available case versus extreme-plausible analyses and random- versus fixed-effect models. To explore possible explanations for heterogeneity, a priori subgroup analysis were conducted on probiotic strain, dose, definition of antibiotic-associated diarrhea, antibiotic agent as well as risk of bias. MAIN RESULTS: Sixteen studies (3432 participants) met the inclusion criteria. Trials included treatment with either Bacillus spp., Bifidobacterium spp., Lactobacilli spp., Lactococcus spp., Leuconostoc cremoris, Saccharomyces spp., or Streptococcus spp., alone or in combination. Nine studies used a single strain probiotic agent, four combined two probiotic strains, one combined three probiotic strains, one product included ten probiotic agents, and one study included two probiotic arms that used three and two strains respectively. The risk of bias was determined to be high in 8 studies and low in 8 studies. Available case (patients who did not complete the studies were not included in the analysis) results from 15/16 trials reporting on the incidence of diarrhea show a large, precise benefit from probiotics compared to active, placebo or no treatment control. The incidence of AAD in the probiotic group was 9% compared to 18% in the control group (2874 participants; RR 0.52; 95% CI 0.38 to 0.72; I(2) = 56%). This benefit was not statistically significant in an extreme plausible (60% of children loss to follow-up in probiotic group and 20% loss to follow-up in the control group had diarrhea) intention to treat (ITT) sensitivity analysis. The incidence of AAD in the probiotic group was 16% compared to 18% in the control group (3392 participants; RR 0.81; 95% CI 0.63 to 1.04; I(2) = 59%). An a priori available case subgroup analysis exploring heterogeneity indicated that high dose (≥5 billion CFUs/day) is more effective than low probiotic dose (< 5 billion CFUs/day), interaction P value = 0.010. For the high dose studies the incidence of AAD in the probiotic group was 8% compared to 22% in the control group (1474 participants; RR 0.40; 95% CI 0.29 to 0.55). For the low dose studies the incidence of AAD in the probiotic group was 8% compared to 11% in the control group (1382 participants; RR 0.80; 95% CI 0.53 to 1.21). An extreme plausible ITT subgroup analysis was marginally significant for high dose probiotics. For the high dose studies the incidence of AAD in the probiotic group was 17% compared to 22% in the control group (1776 participants; RR 0.72; 95% CI 0.53 to 0.99; I(2) = 58%). None of the 11 trials (n = 1583) that reported on adverse events documented any serious adverse events. Meta-analysis excluded all but an extremely small non-significant difference in adverse events between treatment and control (RD 0.00; 95% CI -0.01 to 0.02). AUTHORS' CONCLUSIONS: Despite heterogeneity in probiotic strain, dose, and duration, as well as in study quality, the overall evidence suggests a protective effect of probiotics in preventing AAD. Using 11 criteria to evaluate

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd004827.pub3

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 76

  1. Arvola, 1999, Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study, Pediatrics, 104, e64, 10.1542/peds.104.5.e64 · DOI · Paper page
  2. Benhamou, 1999, Antibiotic-associated diarrhoea in children: A computer monitored double-blind outpatients trial comparing a protective and a probiotic agent, Médecine & Chirurgie Digestives, 28, 163
  3. Contardi, 1991, Oral bacterial therapy in prevention of antibiotic-induced diarrhea in childhood, Clinica Terapeutica, 136, 409
  4. Conway, 2007, Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice, British Journal of General Practice, 57, 953, 10.3399/096016407782604811 · DOI
  5. Erdeve, 2004, The probiotic effect of Saccharomyces boulardii in a pediatric age group, Journal of Tropical Pediatrics, 50, 234, 10.1093/tropej/50.4.234 · DOI
  6. Jirapinyo, 2002, Prevention of antibiotic-associated diarrhea in infants by probiotics, Journal of the Medical Association of Thailand, 85 Suppl 2, s739
  7. Kotowska, 2005, Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial, Alimentary Pharmacology and Therapeutics, 21, 583, 10.1111/j.1365-2036.2005.02356.x · DOI · Paper page
  8. LaRosa, 2003, Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children: A multicentric double-blind vs placebo study, Minerva Pediatrica, 55, 447
  9. Ruszczyński, 2008, Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children, Alimentary Pharmacology and Therapeutics, 28, 154, 10.1111/j.1365-2036.2008.03714.x · DOI
  10. Szajewska, 2009, Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children, Journal of Pediatric Gastroenterology and Nutrition, 48, 431, 10.1097/MPG.0b013e318182e716 · DOI
  11. Szymański, 2008, Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial, Digestion, 78, 13, 10.1159/000151300 · DOI
  12. Tankanow, 1990, A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea, DICP: The Annals of Pharmacotherapy, 24, 382, 10.1177/106002809002400408 · DOI
  13. Vanderhoof, 1999, Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children, Journal of Pediatrics, 135, 564, 10.1016/S0022-3476(99)70053-3 · DOI · Paper page
  14. Brunser, 2006, Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment, Pediatric Research, 59, 451, 10.1203/01.pdr.0000198773.40937.61 · DOI
  15. Can, 2006, Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study, Medical Science Monitor, 12, PI19
  16. Chapoy, 1985, Treatment of acute infantile diarrhea: controlled trial of Saccharomyces boulardii, Annales de Pédiatrie, 32, 561
  17. Czerwionka-Szaflarska, 2006, Effect of probiotic bacteria supplementation on the tolerance of helicobacter pylori eradication therapy in children and youth, Pediatria Polska, 81, 334
  18. Erdeve, 2005, Saccaromyces boulardii and antibiotic-assoiciated diarrhoea in children, Alimentary Pharmacology and Therapeutics, 21, 1508, 10.1111/j.1365-2036.2005.02498.x · DOI
  19. Honeycutt, 2007, Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial, Pediatric Critical Care Medicine, 8, 452, 10.1097/01.PCC.0000282176.41134.E6 · DOI
  20. Kim, 2008, The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication, Helicobacter, 13, 261, 10.1111/j.1523-5378.2008.00601.x · DOI
  21. Koning, 2008, The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin, American Journal of Gastroenterology, 103, 178, 10.1111/j.1572-0241.2007.01547.x · DOI
  22. Lei, 2006, Spontaneously fermented millet product as a natural probiotic treatment for diarrhoea in young children: an intervention study in northern Ghana, International Journal of Food Microbiology, 110, 246, 10.1016/j.ijfoodmicro.2006.04.022 · DOI
  23. Lionetti, 2006, Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial, Alimentary Pharmacology and Therapeutics, 24, 1461, 10.1111/j.1365-2036.2006.03145.x · DOI · Paper page
  24. McFarland, 2005, Can Saccharomyces boulardii prevent antibiotic-associated diarrhea in children?, Nature Clinical Practice Gastroenterology & Hepatology, 2, 262, 10.1038/ncpgasthep0188 · DOI
  25. Michielutti, 1996, Clinical assessment of a new oral bacterial treatment for children with acute diarrhea, Minerva Medica, 87, 545
  26. Savas-Erdeve, 2009, Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children, Turkish Journal of Pediatrics, 51, 220
  27. Schrezenmeir, 2004, Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections, Clinical Pediatrics, 43, 239, 10.1177/000992280404300305 · DOI
  28. Siitonen, 1990, Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea, Annals of Medicine, 22, 57, 10.3109/07853899009147243 · DOI · Paper page
  29. Srinivasan, 2006, Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children, Journal of Pediatric Gastroenterology and Nutrition, 42, 171, 10.1097/01.mpg.0000189335.62397.cf · DOI
  30. Sykora, 2005, Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study, Journal of Clinical Gastroenterology, 39, 692, 10.1097/01.mcg.0000173855.77191.44 · DOI · Paper page
  31. Thomas, 2001, Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial, Mayo Clinic Proceedings, 76, 883, 10.1016/S0025-6196(11)62106-X · DOI · Paper page
  32. Wenus, 2008, Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink, European Journal of Clinical Nutrition, 62, 299, 10.1038/sj.ejcn.1602718 · DOI
  33. Witsell, 1995, Effect of Lactobacillus acidophilus on antibiotic-associated gastrointestinal morbidity: a prospective randomized trial, Journal of Otolaryngology, 24, 230
  34. Zoppi, 2001, Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone, Current Therapeutic Research, 62, 418, 10.1016/S0011-393X(01)89006-8 · DOI
  35. Akl, 2009, LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact, Trials, 10, 40, 10.1186/1745-6215-10-40 · DOI
  36. Beausoleil, 2007, Effect of a fermented milk combining Lactobacillusacidophilus CL1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: A randomized, double-blind, placebo-controlled trial, Canadian Journal of Gastroenterology, 21, 732, 10.1155/2007/720205 · DOI · Paper page
  37. Berrington, 2004, National Clostridium difficile Standards Group: Report to the Department of Health, Journal of Hospital Infection, 56 Suppl 1, 1
  38. Borriello, 2003, Safety of probiotics that contain lactobacilli or bifidobacteria, Clinical Infectious Diseases, 36, 775, 10.1086/368080 · DOI · Paper page
  39. Clarke, 2007, Standardising outcomes for clinical trials and systematic reviews, Trials, 8, 39, 10.1186/1745-6215-8-39 · DOI · Paper page
  40. Cremonini, 2002, Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea, Alimentary Pharmacology and Therapeutics, 16, 1461, 10.1046/j.1365-2036.2002.01318.x · DOI · Paper page
  41. Cunningham-Rundles, 2000, Probiotics and immune response, American Journal of Gastroenterology, 95, S22, 10.1016/S0002-9270(99)00813-8 · DOI · Paper page
  42. D'Souza, 2002, Probiotics in the prevention of antibiotic associated diarrhoea: meta-analysis, BMJ, 324, 1361, 10.1136/bmj.324.7350.1361 · DOI · Paper page
  43. Davis, 2010, A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults, International Journal of Food Microbiology, 144, 285, 10.1016/j.ijfoodmicro.2010.10.007 · DOI · Paper page
  44. Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
  45. Elstner, 1983, Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children, Pediatric Infectious Disease, 2, 364, 10.1097/00006454-198309000-00006 · DOI
  46. Gibson, 1998, Dietary modulation of the human gut microflora using prebiotics, British Journal of Nutrition, 80, S209, 10.1017/S0007114500006048 · DOI · Paper page
  47. Gibson, 2004, Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics, Nutrition Research Reviews, 17, 259, 10.1079/NRR200479 · DOI · Paper page
  48. Gogate, 2005, Diagnostic role of stool culture and toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children, Indian Journal of Medical Research, 122, 518
  49. Goldin, 1998, Health benefits of probiotics, British Journal of Nutrition, 80, S203, 10.1017/S0007114500006036 · DOI · Paper page
  50. Hammerman, 2006, Safety of probiotics: comparison of two popular strains, BMJ, 333, 1006, 10.1136/bmj.39010.630799.BE · DOI
  51. Hata, 1988, Meningitis caused by bifidobacterium in an infant, Pediatric Infectious Disease Journal, 7, 669, 10.1097/00006454-198809000-00018 · DOI
  52. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  53. Ioannidis, 2004, Better reporting of harms in randomized trials: an extension of the CONSORT statement, Annals of Internal Medicine, 141, 781, 10.7326/0003-4819-141-10-200411160-00009 · DOI · Paper page
  54. Johnston, 2006, Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials, CMAJ, 175, 377, 10.1503/cmaj.051603 · DOI · Paper page
  55. Johnston, 2007, Probiotics for the prevention of pediatric antibiotic-associated diarrhea, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004827.pub2 · DOI
  56. Johnston, 2010, Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review, Pediatrics, 126, e222, 10.1542/peds.2009-3667 · DOI
  57. Kale-Pradhan, 2010, Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis, Pharmacotherapy, 30, 119, 10.1592/phco.30.2.119 · DOI
  58. Land, 2005, Lactobacillus sepsis associated with probiotic therapy, Pediatrics, 115, 178, 10.1542/peds.2004-2137 · DOI · Paper page
  59. Mackay, 1999, Lactobacillus endocarditis caused by a probiotic organism, Clinical Microbiology and Infection, 5, 290, 10.1111/j.1469-0691.1999.tb00144.x · DOI · Paper page
  60. Madsen, 2001, The use of probiotics in gastrointestinal disease, Canadian Journal of Gastroenterology, 15, 817, 10.1155/2001/690741 · DOI
  61. McFarland, 1998, Epidemiology, risk factors and treatments for antibiotic-associated diarrhea, Digestive Diseases, 16, 292, 10.1159/000016879 · DOI · Paper page
  62. McFarland, 2008, Antibiotic-associated diarrhea: epidemiology, trends and treatment, Future Microbiology, 3, 563, 10.2217/17460913.3.5.563 · DOI · Paper page
  63. McFarland, 2010, Systematic review and meta-analysis of Saccharomyces boulardiiin adult patients, World Journal of Gastroenterology, 16, 2202, 10.3748/wjg.v16.i18.2202 · DOI · Paper page
  64. Piarroux, 1999, Are live saccharomyces yeasts harmful to patients?, Lancet, 353, 1851, 10.1016/S0140-6736(99)02001-2 · DOI
  65. Rautio, 1999, Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG, Clinical Infectious Diseases, 28, 1159, 10.1086/514766 · DOI · Paper page
  66. Raza, 1995, Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan, Pediatric Infectious Disease Journal, 14, 107, 10.1097/00006454-199502000-00005 · DOI · Paper page
  67. Roberfroid, 1998, Prebiotics and synbiotics: concepts and nutritional properties, British Journal of Nutrition, 80, S197, 10.1017/S0007114500006024 · DOI · Paper page
  68. Saavedra, 1999, Probiotics plus antibiotics: regulating our bacterial environment, Journal of Pediatrics, 135, 535, 10.1016/S0022-3476(99)70046-6 · DOI
  69. Savas-Erdeve, 2009, Efficacy and safety of Saccharomyces boulardii in amebiasis associated diarrhea in children, Turkish Journal of Pediatrics, 51, 220
  70. Sazawal, 2006, Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials, Lancet Infectious Diseases, 6, 374, 10.1016/S1473-3099(06)70495-9 · DOI · Paper page
  71. Schrezenmeir, 2001, Probiotics, prebiotics, and synbiotics -- approaching a definition, American Journal of Clinical Nutrition, 73, 361S, 10.1093/ajcn/73.2.361s · DOI · Paper page
  72. Szajewska, 2005, Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea, Alimentary Pharmacology and Therapeutics, 22, 365, 10.1111/j.1365-2036.2005.02624.x · DOI
  73. Szajewska, 2006, Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials, Journal of Pediatrics, 149, 367, 10.1016/j.jpeds.2006.04.053 · DOI · Paper page
  74. Turck, 2003, Incidence and risk factors for of oral antibiotic-associated diarrhea in an outpatient pediatric population, Journal of Pediatric Gastroenterology and Nutrition, 37, 22, 10.1097/00005176-200307000-00004 · doi:10.1097/00005176-200307000-00004 · Paper page
  75. Wenus, 2008, Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink, European Journal of Clinical Nutrition, 62, 299, 10.1038/sj.ejcn.1602718 · DOI
  76. Wistrom, 2001, Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study, Journal of Antimicrobial Chemotherapy, 47, 43, 10.1093/jac/47.1.43 · DOI · Paper page

Cited by

See all 222

Metadata

Authors
Johnston, B. C., Goldenberg, J. Z., Vandvik, P. O., Sun, X., & Guyatt, G. H.
Venue
Cochrane Database of Systematic Reviews
Published
2011-11-09
Issue
11
Pages
CD004827-CD004827
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4239259475
Cited by
222
References
24
Type
reference entry
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probiotics for the prevention of pediatric antibiotic-associated diarrhea. https://app.cochat.ai/papers/10.1002/14651858.cd004827.pub3
The paper
Johnston, B. C., Goldenberg, J. Z., Vandvik, P. O., Sun, X., & Guyatt, G. H. (2011). Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004827.pub3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.